February 17, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 2 shares of PTC Therapeutics Inc at $70.13 per share, a transaction worth $140.26. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.